دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 30,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی یکماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
قیمت : 3,000,000 تومان- قیمت ویژه : 1,250,000تومان
Subscription Information
doi : 10.1016/S0085-2538(26)00343-1
Volume 110, Issue 1, July 2026, Page A3
In memoriam: Lise Bankir (1942–2026)
doi : 10.1016/j.kint.2026.04.008
Volume 110, Issue 1, July 2026, Pages 2-4
In memoriam: Raymond Ardaillou (1930–2026)
doi : 10.1016/j.kint.2026.04.015
Volume 110, Issue 1, July 2026, Pages 5-7
Finding the etiology of membranoproliferative glomerulonephritis
doi : 10.1016/j.kint.2026.02.030
Volume 110, Issue 1, July 2026, Pages 8-15
Kidney International introduces new article type: Clinical Journey in Translational Medicine
doi : 10.1016/j.kint.2026.04.004
Volume 110, Issue 1, July 2026, Page 16
Proteogenomic dissection of kidney disease and cardiovascular-kidney-metabolic syndrome
doi : 10.1016/j.kint.2025.12.038
Volume 110, Issue 1, July 2026, Pages 19-22
Neglected no longer: lymphatic vessels in the rejecting allograft
doi : 10.1016/j.kint.2026.01.012
Volume 110, Issue 1, July 2026, Pages 23-25
Intercalated cell subtype identity is controlled by reciprocal suppression of transcription factors
doi : 10.1016/j.kint.2026.02.008
Volume 110, Issue 1, July 2026, Pages 26-28
A potential role for effector T cells with Fc receptors in kidney transplant antibody-mediated rejection
doi : 10.1016/j.kint.2026.04.011
Volume 110, Issue 1, July 2026, Pages 29-32
Resolving the VEGF paradox in DKD: VEGFR1 blockade shows promising renoprotection
doi : 10.1016/j.kint.2026.04.006
Volume 110, Issue 1, July 2026, Pages 33-34
What does it mean to win? Interpreting hierarchical kidney outcomes in hypertension trials
doi : 10.1016/j.kint.2026.04.012
Volume 110, Issue 1, July 2026, Pages 35-38
Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?
doi : 10.1016/j.kint.2026.04.005
Volume 110, Issue 1, July 2026, Pages 39-41
Green dialysis: environmentally sustainable care, growth, and innovation: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
doi : 10.1016/j.kint.2026.01.015
Volume 110, Issue 1, July 2026, Pages 42-60
Unique aspects of acute kidney injury associated with infections in the tropics: presentation, challenges, and opportunities
doi : 10.1016/j.kint.2026.02.025
Volume 110, Issue 1, July 2026, Pages 61-69
Kidney cancer screening: novel concepts beyond population-level screening
doi : 10.1016/j.kint.2026.02.039
Volume 110, Issue 1, July 2026, Pages 70-77
Advances in survival analyses: machine learning methods and model comparison
doi : 10.1016/j.kint.2026.02.041
Volume 110, Issue 1, July 2026, Pages 78-88
Intragraft clonal expansion of cytotoxic CD8+ and CD4+ T cells in antibody-mediated kidney transplant rejection
doi : 10.1016/j.kint.2026.03.012
Volume 110, Issue 1, July 2026, Pages 89-98
Reversal of advanced diabetic kidney disease in mice treated with a monoclonal anti-VEGFR1 antibody
doi : 10.1016/j.kint.2026.03.016
Volume 110, Issue 1, July 2026, Pages 99-114
Proteinase 3 drives murine diabetic kidney disease by mediating caspase-3-dependent apoptosis of podocytes
doi : 10.1016/j.kint.2026.02.020
Volume 110, Issue 1, July 2026, Pages 115-129
N-propargylglycine restores survival by preventing calcium oxalate stone formation, tubular injury, and kidney dysfunction in a lethal mouse model of primary hyperoxaluria type 2
doi : 10.1016/j.kint.2026.02.024
Volume 110, Issue 1, July 2026, Pages 130-144
Reduced podocyte stiffness is a feature of proteinuric kidney disease
doi : 10.1016/j.kint.2026.02.028
Volume 110, Issue 1, July 2026, Pages 145-160
Roles of WNK1 and mTORC2 in aldosterone-independent regulation of potassium secretion in the distal nephron
doi : 10.1016/j.kint.2026.03.014
Volume 110, Issue 1, July 2026, Pages 161-177
Individual participant-level analysis of four randomized clinical trials examined therapeutic effects of blood pressure lowering on hierarchical kidney outcome using win statistics
doi : 10.1016/j.kint.2026.02.032
Volume 110, Issue 1, July 2026, Pages 178-189
Genetic testing in kidney transplantation and living kidney donor risk assessment
doi : 10.1016/j.kint.2026.02.033
Volume 110, Issue 1, July 2026, Pages 190-205
Independent association between acute kidney injury and kidney function trajectory
doi : 10.1016/j.kint.2026.03.013
Volume 110, Issue 1, July 2026, Pages 206-213
Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis
doi : 10.1016/j.kint.2026.03.017
Volume 110, Issue 1, July 2026, Pages 214-226
A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease
doi : 10.1016/j.kint.2026.03.020
Volume 110, Issue 1, July 2026, Pages 227-244
A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission
doi : 10.1016/j.kint.2026.02.037
Volume 110, Issue 1, July 2026, Pages 245-254
A missense mutation in the SAA1 protein causing hereditary amyloid A amyloidosis
doi : 10.1016/j.kint.2026.01.035
Volume 110, Issue 1, July 2026, Pages 255-259
Perrault syndrome unmasked: genomic reclassification of a Fabry-like CKDx phenotype
doi : 10.1016/j.kint.2026.01.034
Volume 110, Issue 1, July 2026, Pages 260-262
Light chain crystalline podocytopathy and tubulopathy
doi : 10.1016/j.kint.2025.12.030
Volume 110, Issue 1, July 2026, Page 263
Renal hemosiderosis in paroxysmal nocturnal hemoglobinuria
doi : 10.1016/j.kint.2025.12.033
Volume 110, Issue 1, July 2026, Pages 264-265
When autosomal dominant polycystic kidney disease becomes atypical: aADPKD
doi : 10.1016/j.kint.2025.11.027
Volume 110, Issue 1, July 2026, Page 266
Genitourinary tuberculosis in lupus nephritis
doi : 10.1016/j.kint.2025.10.016
Volume 110, Issue 1, July 2026, Page 267
The Case | Relapsing nephrotic syndrome
doi : 10.1016/j.kint.2026.02.040
Volume 110, Issue 1, July 2026, Pages 268-271
